Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty

Decision models are usually populated 1 parameter at a time, with 1 item of information informing each parameter. Often, however, data may not be available on the parameters themselves but on several functions of parameters, and there may be more items of information than there are parameters to be estimated. The authors show how in these circumstances all the model parameters can be estimated simultaneously using Bayesian Markov chain Monte Carlo methods. Consistency of the information and/or the adequacy of the model can also be assessed within this framework. Statistical evidence synthesis using all available data should result in more precise estimates of parameters and functions of parameters, and is compatible with the emphasis currently placed on systematic use of evidence. To illustrate this, WinBUGS software is used to estimate a simple 9-parameter model of the epidemiology of HIV in women attending prenatal clinics, using information on 12 functions of parameters, and to thereby compute the expected net benefit of 2 alternative prenatal testing strategies, universal testing and targeted testing of high-risk groups. The authors demonstrate improved precision of estimates, and lower estimates of the expected value of perfect information, resulting from the use of all available data.

[1]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and Utilities , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[2]  David R. Jones,et al.  Bayesian methods in health technology assessment: a review. , 2000, Health technology assessment.

[3]  Mitchell J. Small,et al.  Updating Uncertainty in an Integrated Risk Assessment: Conceptual Framework and Methods , 1995 .

[4]  O. N. Gill,et al.  Indirect methods for estimating prevalent HIV infections: adults in England and Wales at the end of 1993 , 1998, Epidemiology and Infection.

[5]  A E Ades,et al.  Use of Anonymous Newborn Serosurveys to Evaluate Antenatal HIV Screening Programmes , 1994, Journal of medical screening.

[6]  R. M. Oliver,et al.  Influence diagrams, belief nets and decision analysis , 1992 .

[7]  Peter Congdon Bayesian statistical modelling , 2002 .

[8]  A E Ades,et al.  Effect of the worldwide epidemic on HIV prevalence in the United Kingdom: record linkage in anonymous neonatal seroprevalence surveys. , 1999, AIDS.

[9]  Gordon B. Hazen,et al.  Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  K Claxton,et al.  An economic approach to clinical trial design and research priority-setting. , 1996, Health economics.

[11]  A E Ades,et al.  Cost effectiveness analysis of antenatal HIV screening in United Kingdom , 1999, BMJ.

[12]  A Nicoll,et al.  Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice. , 1999, AIDS.

[13]  K M Thompson,et al.  Monte Carlo techniques for quantitative uncertainty analysis in public health risk assessments. , 1992, Risk analysis : an official publication of the Society for Risk Analysis.

[14]  John D. Graham,et al.  Going beyond the single number: Using probabilistic risk assessment to improve risk management , 1996 .

[15]  Kaye Wellings,et al.  Sexual Attitudes and Lifestyles , 1994 .

[16]  Families,et al.  Reducing the Odds: Preventing Perinatal Transmission of HIV In The United States , 1999 .

[17]  J. Besag Spatial Interaction and the Statistical Analysis of Lattice Systems , 1974 .

[18]  A Nicoll,et al.  Direct estimates of prevalent HIV infection in adults in England and Wales for 1991 and 1993: an improved method. , 1997, Genitourinary medicine.

[19]  D. Spieglhalter,et al.  Bayesian methods in health technology assessment , 2000 .

[20]  David M. Eddy,et al.  Meta-analysis by the confidence profile method , 1992 .

[21]  A E Ades,et al.  Serotype, parental country of birth, and ethnic status in unlinked anonymous neonatal HIV seroprevalence surveys. , 2000, Journal of acquired immune deficiency syndromes.

[22]  J. Q. Smith,et al.  1. Bayesian Statistics 4 , 1993 .

[23]  Mark Sculpher,et al.  Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling , 2000 .

[24]  David M. Eddy,et al.  The Confidence Profile Method: A Bayesian Method for Assessing Health Technologies , 1989, Oper. Res..

[25]  Ross D. Shachter,et al.  A Bayesian Method for Synthesizing Evidence: The Confidence Profile Method , 1990, International Journal of Technology Assessment in Health Care.

[26]  David M. Eddy,et al.  FAST PRO : software for meta-analysis by the confidence profile method , 1992 .

[27]  Adrian F. M. Smith,et al.  Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[28]  Karl Claxton,et al.  Selecting treatments: a decision theoretic approach , 2000 .

[29]  D J Hu,et al.  The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. , 1996, JAMA.

[30]  Diana M. Gibb,et al.  Vertically transmitted HIV infection in the British Isles. , 1993, BMJ.

[31]  R. Koff,et al.  Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine , 1995 .

[32]  A E Ades,et al.  Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. , 1999, Health technology assessment.

[33]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .

[34]  M J Small,et al.  Risk-based environmental remediation: Bayesian Monte Carlo analysis and the expected value of sample information. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[35]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[36]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[37]  Kimberly M. Thompson,et al.  The Value of Improved National Exposure Information for Perchloroethylene (Perc): A Case Study for Dry Cleaners , 1997 .

[38]  Diana Gibb,et al.  Prevention of mother‐to‐child transmission of HIV‐1 infection: alternative strategies and their cost‐effectiveness , 1998, AIDS.

[39]  A. Rukhin Bayes and Empirical Bayes Methods for Data Analysis , 1997 .

[40]  John Geweke,et al.  Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments , 1991 .

[41]  Howard Raiffa,et al.  Decision analysis: introductory lectures on choices under uncertainty. 1968. , 1969, M.D.Computing.

[42]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[43]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[44]  Robert Schlaifer,et al.  Probability And Statistics For Business Decisions , 1960 .

[45]  Kaye Wellings,et al.  An Estimate of the Prevalence of Human Immunodeficiency Virus Infection in England and Wales by Using a Direct Method , 1994 .

[46]  Ross D. Shachter,et al.  An Introduction to a Bayesian Method for Meta-analysis , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.

[47]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[48]  Alex J. Sutton,et al.  Publication and related biases: a review , 2000 .

[49]  Diana M. Gibb,et al.  Cost-effectiveness of antenatal HIV screening in the UK , 1999 .

[50]  K E Willard,et al.  Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.

[51]  A E Ades,et al.  Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96 , 1998, BMJ.